The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
GMS Health Innovation and Technologies · 16.03.2022 · 16 (Doc02) · Doc02-Doc02
DOI: 10.3205/hta000134 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift GMS Health Innovation and Technologies, erschienen am 16.03.2022. Verfasst von Hsin-Yi Tsai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Technology Assessment, Center for Drug Evaluation, Taipei, Taiwan. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Medical technology is undergoing rapid transformations, and the classifications of medical devices have also expanded greatly; therefore, it is necessary to develop appropriate reimbursement policies and pricing mechanisms in a timely manner. This paper aims to introduce the reimbursement coverage and pricing rules for medical devices in Taiwan. In addition, this paper identifies and evaluates available health technology assessments (HTA) and literature on published websites concerning medical device decision-making processes and pricing systems in South Korea and Japan, which are near Taiwan and have similar reimbursement coverage processes. Reimbursement policy and pricing mechanisms are constantly being revised in Taiwan, Japan, and South Korea. Recently, all three countries attempted to establish new reimbursement coverage decision-making and pricing rules, adopting a differentiated approach based on the level of evidence required for the appropriated reimbursement in terms of a feasible evaluation mechanism for providing patients with more effective medical devices. This article is expected to contribute to providing references to new reimbursement coverage decision-making and pricing rules.
Schlagwörter
Autor:innen und Institutionen
- Division of Health Technology Assessment, Center for Drug Evaluation, Taipei, Taiwan.
- National Health Insurance Administration, Ministry of Health and Welfare, Taipei, Taiwan.
- College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Medical Devices Reimbursement Committee of Taiwan, Tainan, Taiwan.
- Departement of Surgery, College of Medicine, National Cheng Kung University, Tainain, Taiwan.
Zitieren
APA
Tsai, H. Y., Huang, Y. W., Chang, S. Y., Huang, L. Y., Lin, C. J., & Lee, P. C. (2022). The reimbursement coverage decisions and pricing rules for medical devices in Taiwan. GMS Health Innovation and Technologies, 16(Doc02), Doc02-Doc02. https://doi.org/10.3205/hta000134
Vancouver
Tsai HY, Huang YW, Chang SY, Huang LY, Lin CJ, Lee PC. The reimbursement coverage decisions and pricing rules for medical devices in Taiwan. GMS Health Innovation and Technologies. 2022;16(Doc02):Doc02-Doc02. doi:10.3205/hta000134
BibTeX
@article{Tsai2022,
author = {Tsai, Hsin-Yi and Huang, Yu-Wen and Chang, Shu-Ya and Huang, Li-Ying and Lin, Chii Jeng and Lee, Po-Chang},
title = {The reimbursement coverage decisions and pricing rules for medical devices in Taiwan},
journal = {GMS Health Innovation and Technologies},
year = {2022},
volume = {16},
number = {Doc02},
pages = {Doc02--Doc02},
doi = {10.3205/hta000134}
}
EUVIMED